Your browser doesn't support javascript.
loading
Antinociceptive effects of ceftriaxone in formalin-induced nociception.
Baeza-Flores, Guadalupe Del Carmen; Rodríguez-Palma, Erick J; Reyes-Pérez, Valeria; Guzmán-Priego, Crystell G; Torres-López, Jorge E.
Afiliación
  • Baeza-Flores GDC; Pain Mechanisms Laboratory, División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco, Villahermosa, Mexico.
  • Rodríguez-Palma EJ; Neurobiology of Pain, Departamento de Farmacobiología, Cinvestav, Sede Sur, Mexico City, Mexico.
  • Reyes-Pérez V; Faculty of Chemistry, Facultad de Química, UNAM, Mexico City, Mexico.
  • Guzmán-Priego CG; Pain Mechanisms Laboratory, División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco, Villahermosa, Mexico.
  • Torres-López JE; Pain Mechanisms Laboratory, División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco, Villahermosa, Mexico.
Drug Dev Res ; 81(6): 728-735, 2020 09.
Article en En | MEDLINE | ID: mdl-32394536
ABSTRACT
Ceftriaxone (CFX) is a ß-lactam antibiotic with analgesic properties. However, its role in the formalin-induced nociception remains unknown. The purpose of this study was to investigate the antinociceptive effect of CFX in the 1% formalin test in rats. Formalin induced a typical nociceptive response (flinching behavior) of two phases. Local peripheral pretreatment (20 min) with CFX (400-800 µg/paw) slightly attenuated the flinching behavior in phase 2, but not phase 1. Acute intraperitoneal pretreatment (20 min) also reduced phase 2 of the formalin test. In both cases, CFX induced a dose-dependent antinociception. We also tested the effect of CFX 1 day after its administration and in two schedules of repeated administration. One-day pretreatment with CFX (50-400 mg/kg, ip) induced a dose-dependent antinociceptive effect in formalin-treated rats. Repeated administration (daily during 3 or 7 days) with CFX (50-400 mg/kg, ip) diminished formalin-induced nociception. Results suggest that local or systemic as well as single or repeated administration of CFX reduces formalin-induced nociception.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dolor / Ceftriaxona / Nocicepción / Analgésicos / Antibacterianos Límite: Animals Idioma: En Revista: Drug Dev Res Año: 2020 Tipo del documento: Article País de afiliación: México

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dolor / Ceftriaxona / Nocicepción / Analgésicos / Antibacterianos Límite: Animals Idioma: En Revista: Drug Dev Res Año: 2020 Tipo del documento: Article País de afiliación: México